about
Inflammatory breast cancer in Tunisia from 2005 to 2010: epidemiologic and anatomoclinical transitions from published data.[Nasopharyngeal carcinoma. Recent data]Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient's follow up?Glioblastoma in Tunisia: A retrospective study about 41 cases.Nasopharyngeal cancer (NPC) around the Mediterranean area: standard of care.Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features.[Role of radiotherapy in the treatment of small cell lung carcinoma][Invasive carcinoma of the cervix in young women in Tunisia][The status of hormone therapy in breast cancer in 2001?][Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].[Primary sino-nasal lymphomas. Apropos of 25 cases][Struma ovarii. Analysis of a series of 7 cases and review of the literature].Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix.[Mucous malignant melanoma of the neck and face. Experience at the Salah Azaiz Institute (Tunis)][Medulloblastoma with extracentral nervous system metastases: clinical presentation and risk factors].Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.[Secondary breast cancer after treatment for Hodgkin's disease. About seven cases][Epidemiology of nasal and paranasal sinus cancer in Tunisia][Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases].P17.11COMBINED RADIOTHERAPY(RT) AND CHEMOTHERAPY(CT) WITH TEMOZOLOMIDE(TMZ) CONCOMITANT(CC) AND ADJUVANT(ADJ) IN GLIOBLASTOMA IN TUNISIA(TN): RETROSPECTIVE STUDY ABOUT 37 CASES.[Clinical and evolutive aspects of nasopharyngeal T4 N0 neoplasms].[Metachronous cancers after treatment for undifferentiated nasopharyngeal carcinoma][Intraoperative brachytherapy in the management of keloids. Apropos of 114 cases] .[Primitive intracranial ependymomas. Salah-Azaîz institute experience][Primary intramedullary ependymomas: retrospective study of 16 cases]Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences[Reliability and value of cytology in breast lesions][Results of the combination of radiation-surgery in the treatment of cancer proximal stage I and II of the cervix uteri][Liposarcoma: clinical study and therapeutic results (46 cases)][Curie therapy of cancer of the uterine neck: technics, indications, results][Prophylactic brain irradiation in small cell bronchial carcinomas]Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients[Struma ovarii: three case reports][Chemotherapy in small-cell anaplastic bronchial carcinoma (apropos of 6 case reports). Preliminary results][Conservative treatment of cancer of the breast in Tunisia][Thyroid oncocytomas][Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature][Dermatomyositis and nasopharyngeal carcinoma: 3 cases][Secondary mandibular fibrosarcoma after chemoradiotherapy for undifferentiated nasopharyngeal carcinoma. Report of a case and review of the literature][Ovarian cancer associated with pregnancy, report of 3 cases]
P50
Q30903361-F16DC643-9351-46B3-A2E5-1692D61E348EQ33210391-77939AF1-BCE3-49BE-8EF1-50FCBF6BA896Q35528917-B5924FF4-B48C-4BE3-9EC9-08AE68D187A1Q35928600-EEBA6B34-B22C-4C77-8EC0-D9E408FABEE7Q37822981-C6285ECA-021E-4364-A30A-98EF1486277DQ38917896-4CFB6081-D699-40D0-A72A-DBFF1D749D4AQ43709908-7C9F4981-1FE3-4ED8-AB3D-F292053CE7A7Q43995690-7901E9CE-2E94-45B1-893C-85DDC74889D5Q44335583-C5AD2598-1D70-44E4-B2EA-DC0F1B72D917Q44604742-E4693402-5DF6-4B48-98FF-658B915652E1Q46164616-B541B170-DD73-4FA8-ACA3-5B84BA0669D9Q46181053-0ACD0F78-F28B-4F88-9F14-C19F68B75342Q46196592-1BBF34A7-4CFA-425E-8311-E5CDDC8899A0Q46232125-7AF5780F-DC42-4A59-BA11-80441A32E8AFQ46234885-7012E528-744B-4A23-9542-CC15D7EAEF89Q46511043-0A0001F7-83B8-447F-B244-0FA2EC5D23EEQ46679474-4C5D5729-AE87-432F-AE1E-FA2377768F6CQ46716716-F0DBCB34-5E08-44E1-A4E0-B13B47D2FCE6Q46826959-BC960634-37E1-4AA8-A013-8C5F09BC7D6DQ46884637-64F6187F-6BCA-412A-9999-496198B290E5Q51047352-66DF7A30-4347-4CE8-AA2A-D21A9DD1FA78Q54122049-EAEA468F-832C-463F-BAB1-975BD662063AQ54127198-CE82BC6F-5D7A-40FF-BD78-719490B97726Q55472238-26EA591B-C643-400B-BB06-D6D248A8EE0DQ55472954-664B30DD-2972-4CB1-96E1-99AB02C3FA1FQ67916229-71822A9B-59DE-4370-A816-E35BEE49617FQ68845487-C1074F74-3135-4915-8271-27D73681EE7BQ68846058-B60C4DAF-6825-4305-B8B8-509F48EF3410Q69521505-572FECB0-1DEC-452F-A108-BD604EA05AC3Q69581349-C88A0266-07F3-47F0-95EB-86ED88A511A0Q69813641-60B7D4B6-A596-4548-A990-8B9670F47105Q69822544-C3EAF0FB-8256-4E35-829C-63BE4CD99BC7Q72156064-4EECBA9C-C184-4717-9D8F-1F91E6C18D3FQ72412364-0CB3D185-58E0-47C2-B1DC-1E603DEA8625Q72880196-A2689D34-A552-4F45-BA79-C944D3A607B7Q73336396-B63CDDC4-84A0-4B75-BBE4-8D91B348AFAFQ73471331-E2720C49-A345-41C2-BE1C-3057E8DAFEE7Q73871767-3B85214B-CADA-444D-B16D-E51D4C2A1303Q74168319-3D4A1ECD-5C46-4725-BCD7-1255D30B861CQ74321866-5905A393-6717-4780-A84B-7587D78BBE48
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Farouk Benna
@ast
Farouk Benna
@en
Farouk Benna
@es
Farouk Benna
@nl
Farouk Benna
@sl
type
label
Farouk Benna
@ast
Farouk Benna
@en
Farouk Benna
@es
Farouk Benna
@nl
Farouk Benna
@sl
prefLabel
Farouk Benna
@ast
Farouk Benna
@en
Farouk Benna
@es
Farouk Benna
@nl
Farouk Benna
@sl
P106
P21
P31
P496
0000-0001-5824-0099
P569
2000-01-01T00:00:00Z